Formulation and Development of Transdermal Patches of Piroxicam
DOI:
https://doi.org/10.22270/ajprd.v7i3.511Keywords:
Hydroxyl propyl methyl cellulose, ethyl cellulose, poly vinyl pyrrolidone, PiroxicamAbstract
The aim of the given study was to formation as well as development of patches of piroxicam. Piroxicam basically a steroidal anti-inflammatory drug. Less dosage result in the longer duration of action which make these patches a remarkable in curing the infection for the increase of transdermal properties of the patches various batches were prepared using hydroxyl propyl methyl cellulose, ethyl cellulose and poly vinyl pyrrolidone for best result various parameters are considered like thickness,weight are considered during various test in different batches and the last are i.e. the 6th batch comes good result batch 6th show best evaluation parameter whereas batch 7th show a 95 % release of drug there parameters including moisture content and above mention were tested and were evaluated for best possible result.
Downloads
References
2. Saroha K, Yadav B and Sharma B: Transdermal patch: A discrete dosage form. International Journal of Current Pharma Research. 2011; 3:98-108.
3. Vinod KR, Sarvani P, Banji D and Teja BB: Transdermal drug delivery systemover coming challenges of popular drug delivery system. International Journal of Pharma World Research. 2010; 1:1-14.
4. Jain A, Mishra A, Nayak S and Soni V: Transdermal delivery of antihypertensive agents: A tabular update. International Journal of Drug Delivery. 2011; 3:1-13.
5. Sharma N, Agarwal G, Rana AC, Bhat Z and Kumar D: A Review: Transdermal drug delivery system: A tool for novel drug delivery system. International Journal of Drug Development and Research. 2011; 3:70-84.
6. Sampathkumar KP, Debjit B, Chiranjib B and Chandira RM: Transdermal drug delivery system-a novel drug delivery system and its market scope and opportunities. International Journal of Pharmacy and Bio Sciences. 2010; 1:1-21.
7. Patel D, Patel N, Parmar M and Kaur N: Transdermal drug delivery system: Review. International Journal of Biopharm and Toxicological Research. 2011; 1:61-80.
8. Baria AH and Patel RP: Formulation and evaluation considerations of transderma drug delivery system. International Journal of Pharmaceutical Research. 2011; 3:1-9.
9. Bhargava T, Ramchandani U, Shrivastava SK and Dubey PK: Current trends in NDDS with special reference to NSAIDs. International Journal of Pharmacy and Bio Sciences 2011; 2: 92-114.
10. Patel D, Sunita A. Chaudhary, Bhavesh Parmar, NikunjBhura. Transdermal drug delivery system: a review, vol-2, 2011, page no.78-88.
11. Baker W and Heller J.”Material Selection for Transdermal Delivery Systems”, In Transdermal Drug Delivery: Developmental Issues and Research Initiatives, J.Hadgraft and R.H.Guys, Eds. Marcel Dekker, Inc.,Newyork 1989 pp. 293-311.
12. Baker W and Heller J.”Material Selection for Transdermal Delivery Systems”, In Transdermal Drug Delivery: Developmental Issues and Research Initiatives, J.Hadgraft and R.H.Guys, Eds. Marcel Dekker, Inc.,Newyork 1989 pp. 293-311.
13. Wiechers J. Use of chemical penetration enhancers in Transdermal drug delivery- possibilities and difficulties. Acta pharm. 1992 ; 4:123.
14. Yamamoto T, Katakabe k, Akiyoshi K, Kan K and Asano T. Topical application of glibenclamide lowers blood glucose levels in rats. Diabetes res. Clin. Pract. 1990; 8:19-22.
15. Al- Khamis K, Davis S.S and Hadgraft J. Microviscosity and drug release from topical gel formulations. Pharm. Res. 1986; 3: 214-217.
16. Anon. Transdermal delivery systems-general drug release standards. Pharmacopeial Forum, 1980; 14:3860-3865.
17. Mayorga P, Puisieux F and Couarraze G. Formulation study of a Transdermal delivery system of primaquine. Int. J. pharm. 1996; 132:71-79.
18. Deo M.R, SantV.P,Parekh S.R, Khopade A.J and Banakar U.V. Proliposome-based Transdermal delivery of levonorgestrel. Jour. Biomat. Appl. 1997; 12:77-88.
19. Yan-yu X, Yun- mei S, Zhi-Peng C and Qi-nerg P. Preparation of silymarinproliposomes; A new way to increase oral bioavailability of silymarin in beagle dogs. Int. pharm. 2006; 319:162-168.
20. Crawford R.R and Esmerian O.K. Effect of plasticizers on some physical properties of cellulose acetate phthalate films. J. Pharm. Sci. 1997; 60:312- 314.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).